Publications by authors named "J Peske"

Claim this Profile
T
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.
Jiaxin Ge, Joshua Urban, Sarah R DiNapoli, Bum Seok Lee, Taha Ahmedna, J David Peske

Nat Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML.
Theodoros Karantanos, Nour Naji, Taha Ahmedna, J Peske, Xinghan Zeng

Res Sq· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML.
Nour Sabiha Naji, Taha Ahmedna, J David Peske, Xinghan Zeng, Brandy Perkins

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The real-world application of T-cell receptor constant beta-1 chain antibody assay in cutaneous T-cell lymphoma.
Olivia Pierog, Taylor Craig, Jacky Jennings, Michael J Borowitz, Ananya Munjal, J David Peske

Br J Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CCRL2 enhances therapeutic outcomes in a tuberculosis mouse model.
Tianyin Wang, Darla Quijada, Taha Ahmedna, Jennie Ruelas Castillo, Nour Sabiha Naji, J David Peske

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis